Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# EOM Pharmaceuticals, Inc.

Powering Relentless Science

## Sitemaps

- [XML Sitemap](https://eompharma.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613](https://eompharma.com/news-highlights/eom-pharmaceutical-holdings-provides-an-update-on-its-lead-drug-candidate-eom613/)
- [EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil](https://eompharma.com/news-highlights/eom-pharmaceutical-holdings-announces-topline-results-of-its-covid-19-clinical-trial-of-eom613-in-brazil/)
- [EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.](https://eompharma.com/news-highlights/eom-pharmaceutical-holdings-inc-announces-name-change-from-immunocellular-therapeutics-ltd/)
- [EOM PHARMACEUTICALS, INC. AND IMMUNOCELLULAR THERAPEUTICS, LTD. ANNOUNCE  ENTRY INTO AND CLOSE OF DEFINITIVE MERGER AGREEMENT](https://eompharma.com/news-highlights/eom-pharmaceuticals-inc-and-immunocellular-therapeutics-ltd-announce-entry-into-and-close-of-definitive-merger-agreement/)
- [EOM PHARMACEUTICALS ANNOUNCES FIRST PATIENTS DOSED IN R1: RESCUE PHASE 1/2A OPEN-LABEL TRIAL EVALUATING EOM613 IN HOSPITALIZED COVID-19 PATIENTS WITH SEVERE SYMPTOMS IN BRAZIL](https://eompharma.com/news-highlights/eom-pharmaceuticals-announces-first-patients-dosed-in-r1-rescue-phase-1-2a-open-label-trial-evaluating-eom613-in-hospitalized-covid-19-patients-with-severe-symptoms-in-brazil/)
- [EOM PHARMACEUTICALS APPOINTS DRUG DEVELOPMENT VETERAN FRANK L. DOUGLAS, Ph.D., M.D., SCIENTIFIC ADVISOR](https://eompharma.com/news-highlights/eom-pharmaceuticals-appoints-drug-development-veteran-frank-l-douglas-ph-d-m-d-scientific-advisor/)
- [EOM PHARMACEUTICALS ANNOUNCES ITS PRE-IND MEETING REQUEST WITH U.S. FDA TO EVALUATE PLANS FOR A PHASE 2 CLINICAL TRIAL OF ITS INVESTIGATIONAL DUAL-ACTING, BROAD-SPECTRUM IMMUNOMODULATOR IN COVID-19 PATIENTS](https://eompharma.com/news-highlights/eom-pharmaceuticals-announces-its-pre-ind-meeting-request-with-u-s-fda-to-evaluate-plans-for-a-phase-2-clinical-trial-of-its-investigational-dual-acting-broad-spectrum-immunomodulator-in-covid-19-pa/)
- [EOM PHARMACEUTICALS APPOINTS BUSINESS VETERAN WAYNE I. DANSON AS CHIEF FINANCIAL OFFICER AND TREASURER](https://eompharma.com/news-highlights/eom-pharmaceuticals-appoints-business-veteran-wayne-i-danson-as-chief-financial-officer-and-treasurer/)

## Pages

- [Home](https://eompharma.com/home/)
- [News & Media](https://eompharma.com/news-media/)
- [About EOM](https://eompharma.com/about-eom/)
- [Clinical Trials](https://eompharma.com/clinical-trials/)
- [Powering Relentless Science](https://eompharma.com/powering-relentless-science/)
- [EOM Pipeline](https://eompharma.com/pipeline/)
- [Our Focus: Serving Patients](https://eompharma.com/focus/)
- [Terms & Conditions](https://eompharma.com/terms-conditions/)
- [Privacy Policy](https://eompharma.com/privacy-policy/)
- [Contact Us](https://eompharma.com/contact-us/)

## Categories

- [News Highlights](https://eompharma.com/news-highlights/)
- [Press Release Archive](https://eompharma.com/press-release-archive/)